Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now small index

Cancer-related Cognitive Dysfunction clinical trials

2 of 2 indexed Cancer-related Cognitive Dysfunction trials are currently recruiting.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Cancer-related Cognitive Dysfunction: 2 US clinical trials tracked, 2 recruiting.

Cancer-related Cognitive Dysfunction is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. The most active sponsor is Emory University, running 1 of these trials.

Enrollment posture brief

Registry condition cancer-related-cognitive-dysfunction

OPEN 2 | RECR 100% | LATE 0 | EARLY 0 | RANK #7188 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Cancer-related Cognitive (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Cancer-related Cognitive Dysfunction

Cancer-related Cognitive Dysfunction lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Cancer-related Cognitive Dysfunction on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Cancer-related Cognitive Dysfunction is recruiting above its size-band peers.

    2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Emory University 1 trials
Mayo Clinic 1 trials

Named interventions

Most-linked intervention names on Cancer-related Cognitive Dysfunction records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Aerobic Exercise Other
1 trials
Internet-Based Intervention Other
1 trials
Health Education (Active comparator) Other
1 trials
Follow-Up Procedure
1 trials
Aerobic Exercise Training Behavioral
1 trials
Behavioral Intervention Behavioral
1 trials
Medical Device Usage and Evaluation Other
1 trials

US sites by state

Facility locations filed on Cancer-related Cognitive Dysfunction trials. A trial with sites in several states counts in each.

Texas 1 trials
Georgia 1 trials
Arizona 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Cancer-related Cognitive Dysfunction page

2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 2 Cancer-related Cognitive Dysfunction trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Emory University sponsors the most Cancer-related Cognitive Dysfunction trials on record, review their full trial history before evaluating a specific study. See Emory University's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cancer-related Cognitive Dysfunction condition card totals 2 registered trials; most-linked intervention Aerobic Exercise; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.